VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,104,067 | -33.1% | 83,263 | -5.5% | 0.00% | -100.0% |
| Q2 2023 | $1,651,388 | +26.1% | 88,074 | -3.0% | 0.00% | – |
| Q1 2023 | $1,309,841 | -72.2% | 90,835 | -62.7% | 0.00% | -100.0% |
| Q4 2022 | $4,717,027 | +307.7% | 243,774 | +623.3% | 0.00% | +100.0% |
| Q3 2022 | $1,157,000 | +57750.0% | 33,703 | +22368.7% | 0.00% | – |
| Q2 2022 | $2,000 | -99.9% | 150 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $2,424,000 | +170.2% | 106,251 | +336.7% | 0.00% | – |
| Q4 2021 | $897,000 | +478.7% | 24,330 | +637.3% | 0.00% | – |
| Q3 2021 | $155,000 | +68.5% | 3,300 | +115.5% | 0.00% | – |
| Q2 2021 | $92,000 | – | 1,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |